In the absence of any published information on the indications, frequency, and outcomes of revision augmentation/mastopexy, an 8-year retrospective review was undertaken of all patients undergoing revision of a previous augmentation/mastopexy in the senior author's practice. The data collected included original implant type, location and mastopexy type, indication for revision, interval from original surgery, new implant type, location, and associated corrective surgical procedures. A simultaneous review was also performed of all primary augmentation/mastopexies done during the same period.
B reast ptosis, as described by Regnault, 1 is due to a discrepancy between breast volume and the overlying skin envelope. Surgical correction consists of increasing breast volume, reducing the skin envelope, or a combination of both in the form of an augmentation/mastopexy. A variety of procedures have been described with this in mind. [2] [3] [4] [5] While primary augmentation/mastopexy has been previously addressed, a search of the medical literature does not reveal any information on secondary or revision augmentation/mastopexy. In the absence of any published information on the frequency, indications, techniques, and outcomes of revision augmentation/mastopexy, an 8-year retrospective review was organized. The number of primary augmentation/mastopexies performed during the same time period was also reviewed for reference.
MATERIALS AND METHODS
The office and hospital records of all women operated on by the senior author (SLS) who underwent primary or revision augmentation/mastopexy in the 8-year period between January 1993 and December 2001 were reviewed. Parameters studied included original implant type and location, original mastopexy type, indication for revision, duration from original surgery, new implant type and location, new mastopexy type, and type of corrective surgical procedure. In addition, duration of follow-up and outcomes was recorded. Indications for reoperation were based both on specific patient dissatisfaction with their original surgery and surgeon's physical examination and assessment.
RESULTS
A total of 20 patients underwent revision augmentation/ mastopexy, while during the same period, 40 patients underwent primary augmentation/mastopexy. Of the 20 revisions, 14 were bilateral and 6 were unilateral, for a total of 34 breasts. Four patients had 1 prior revision, and 1 patient had 3 prior revisions. Of these 5 patients, 3 had all of their procedures performed by the senior author. The remaining patients had no prior revisions. The majority of 20 patients requiring revision (75%) had their initial primary augmentation/mastopexy done elsewhere. The average age of the revision augmentation/mastopexy patients was 47 years (range 30 -64). The average age of the primary augmentation/mastopexy patients was 40 years (range 25-64).
There were 8 common indications for revision (Table  1) . These included capsular contracture in 11 of 20 patients (55%), nipple ptosis in 11 of 20 patients (55%), implant malposition in 7 of 20 patients (35%), dissatisfaction with implant size in 6 of 20 patients (30%), poor scar in 5 of 20 patients (25%), breast ptosis in 4 of 20 patients (20%), nipple malposition in 2 of 20 patients (10%), and patient preference in 1 (5%) patient. Of the 6 patients who were dissatisfied with their previous implant size, 4 (66.7%) felt their implants were too small, while 2 (33.3%) felt their implants were too big. Among the 2 patients whose nipples were malpositioned, 1 (50%) was too high and 1 (50%) was too lateral. Most patients had at least 2 indications for revision at the time of presentation ( Table 2) . Four of 20 patients (20%) had 1 indication for revision, 8 of 20 patients (40%) had 2 indications for revision, 6 of 20 patients (30%) had 3 indications for revision, and 2 of 20 patients (10%) had 4 indications for revision. The average interval from original surgery to revision was 7 years (range 5 months to 20 years).
At the time of revision, 13 of 20 patients (65%) received the same type of implant. Three of 20 patients (15%) were converted from saline to silicone; 1 out of the 20 patients (5%) was converted from silicone to saline, and 3 of 20 patients (15%) had their silicone gel implants replaced with new silicone implants. At the time of revision, 12 of 20 patients (60%) required no change in implant location. In 3 of 20 patients (15%), the implant was switched from the subglandular position to the partly subpectoral or dual-plane position. In 5 of 20 patients (25%), the implant was repositioned from a submuscular to a partly subpectoral or dualplane position.
In 18 of 20 patients (90%), no change in mastopexy type was needed, whereas in 2 of 20 patients (10%), a change was performed. One patient had a periareolar mastopexy converted to a vertical mastopexy, while the other patient had a vertical mastopexy converted to an inverted-T type.
Corrective surgical procedures performed during the revision included repeat mastopexy, capsulectomy, change of implant type, change of implant location, change of implant size, capsulotomy, capsulorrhaphy, and scar revision (Table  3) . Eighteen patients (90%) had a repeat mastopexy, 8 patients (40%) had capsulectomies, 7 patients (35%) had a change of implant type, 7 patients (35%) had a change of implant location, 6 patients (30%) had a change of implant size, 3 patients (15%) had capsulotomies, 2 patients (10%) had capsulorrhaphies, and 2 patients (10%) had scar revisions.
To date, all patients are satisfied with the appearance of their breasts. Follow-up ranges from 2 months to 4 years, with an average follow-up of 2 years. Representative examples of patients are shown in Figures 1, 2, 3 , and 4. 
DISCUSSION
It is generally accepted that simultaneous augmentation/mastopexy is a somewhat difficult and unpredictable procedure. [2] [3] [4] [5] A reasonable approach to the hypoplastic ptotic breast may well be to stage the augmentation and mastopexy. While the challenges and some of the complications of simultaneous augmentation/mastopexy are already known, no one has yet identified the common problem or problems that might lead to reoperation in these patients. 6, 7 There are both short-term and long-term concerns at play. In the short run, mastopexy has the potential for making breast augmentation more difficult by creating a greater possibility of wound complications in the presence of a breast implant. Breast augmentation has the potential for making mastopexy more complex by changing the volume of the breast, repositioning the inframammary fold, and devascularizing the breast. These short-term concerns or potential complications were not specifically the subject of this review. Rather, because of what appeared to be a significant number of late revisions in our practice, we were curious to see if there were any patterns or trends that would be worthwhile elucidating in terms of causation or prevention.
From a theoretical point of view, for example, one could ask whether more augmentation/mastopexies would need to be redone because the nipple was positioned or migrated superiorly or because it was positioned or migrated inferiorly? When revising other surgeons' work, it can be difficult to determine whether late problems are a result of initial errors in planning or execution or the consequences of long-term unpredictable natural events. In the review of the revisions of our own patients, however, we can draw more inferences.
There are a number of results of this study that bear emphasis. First, revision augmentation/mastopexy is not an uncommon procedure. In our series of patients, revision augmentation/mastopexy in a given time frame is performed almost half as commonly as primary augmentation mastopexy (during the 8-year period, 80 primary procedures were performed in 40 patients, while 34 revisions were done in other 20 patients). according to our experience, one could argue that there is a significant likelihood that a woman undergoing such a procedure would need a revision.
Eighty percent of patients requiring revision had 2 or more indications for surgery. The most common indications were implant related, that is, capsular contracture, implant malposition, and dissatisfaction with implant size. Implantrelated indications for revision augmentation/mastopexy can be addressed with capsulectomy, capsulotomy, capsulorrhaphy, and change of implant type, location, or size.
There is certainly the possibility that the incidence of implant-related reoperations may diminish in the future. Recent changes in implants appear to have reduced the inci- 15, 16 cohesive silicone gels, 17, 18 and subpectoral positioning 19, 20 all have been shown to reduce the incidence of encapsulation. However, superior migration or, conversely, bottoming out can still happen and may lead to revision or reoperation.
With the mastopexy portion of the procedure, there is the possibility of positioning the nipple too high, positioning it too low, or having ptosis recur over time. Despite the generalized concern over placing the nipple too high, most of our patients had revisions for recurring or undercorrected ptosis. In most patients (90%), repeat of the original type of mastopexy was sufficient, but in some (10%), a more aggressive type of procedure was required.
Poor periareolar scarring secondary to performance of the mastopexy may be diminished or alleviated by the use of a circumferential and permanent suture placed along the dermal edge. We have found this to reduce scalloping and irregularities.
In summary, augmentation/mastopexy is significantly more complicated than augmentation or mastopexy alone. In addition to increased perioperative risk, we postulate a significant risk of late revision. While many of these patients may present with implant related problems, approximately 90% will benefit from revision or repeat of their original mastopexy. Patients undergoing augmentation/mastopexy should be advised about both about short-term risks and the likelihood of long-term revision.
